Danny Prosky
Known title: CEO & PresidentCIK: 0001433671
Danny Prosky's purchase track record
Danny Prosky has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/22/2024 | AHR | $355K | +42.5% | +101.5% | +11.5% |
| 2/9/2024 | AHR | $1000K | +8.7% | +31.9% | +6.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AHR | ▼ Sell | Tax Withholding | 59,945 | $3.4M | 7/21/2026 | View on chart |
| AHR | ▲ Buy | Option Exercise | 30,886 | — | 7/21/2026 | View on chart |
| AHR | ▼ Sell | Tax Withholding | 16,663 | $944K | 7/21/2026 | View on chart |
| AHR | ▲ Buy | Option Exercise | 20,912 | — | 7/21/2026 | View on chart |
| AHR | ▼ Sell | Tax Withholding | 11,283 | $639K | 7/21/2026 | View on chart |
| AHR | ▲ Buy | Grant | 2,594 | $0 | 7/21/2026 | View on chart |
| AHR | ▲ Buy | Option Exercise | 15,924 | — | 4/6/2026 | View on chart |
| AHR | ▼ Sell | Tax Withholding | 8,596 | $413K | 4/6/2026 | View on chart |
| AHR | ▲ Buy | Option Exercise | 30,885 | — | 3/25/2026 | View on chart |
| AHR | ▼ Sell | Tax Withholding | 15,715 | $758K | 3/25/2026 | View on chart |
| AHR | ▲ Buy | Option Exercise | 20,912 | — | 3/25/2026 | View on chart |
| AHR | ▼ Sell | Tax Withholding | 10,641 | $513K | 3/25/2026 | View on chart |
| AHR | ▲ Buy | Option Exercise | 31,846 | — | 3/12/2026 | View on chart |
| AHR | ▼ Sell | Tax Withholding | 17,181 | $907K | 3/12/2026 | View on chart |
| AHR | ▼ Sell | Tax Withholding | 29,992 | $1.5M | 2/9/2026 | View on chart |
| AHR | ▲ Buy | Option Exercise | 15,924 | — | 4/3/2025 | View on chart |
| AHR | ▲ Buy | Option Exercise | 30,885 | — | 3/25/2025 | View on chart |
| AHR | ▲ Buy | Option Exercise | 11,718 | — | 3/14/2025 | View on chart |
| AHR | ▼ Sell | Other | 47,219 | — | 8/5/2024 | View on chart |
| AHR | ▼ Sell | Other | 47,219 | — | 8/5/2024 | View on chart |
| AHR | ▼ Sell | Other | 80,986 | — | 8/5/2024 | View on chart |
| AHR | ▼ Sell | Other | 12,085 | — | 8/5/2024 | View on chart |
| AHR | ▼ Sell | Other | 12,084 | — | 8/5/2024 | View on chart |
| AHR | ▼ Sell | Other | 80,986 | — | 8/5/2024 | View on chart |
| AHR | ▲ Buy | Open Market | 25,000 | $355K | 5/22/2024 | View on chart |
| AHR | ▲ Buy | Option Exercise | 15,923 | — | 4/3/2024 | View on chart |
| AHR | ▲ Buy | Grant | 222,222 | $0 | 2/9/2024 | View on chart |
| AHR | ▲ Buy | Open Market | 83,333 | $1000K | 2/9/2024 | View on chart |
| AHR | ▼ Sell | Tax Withholding | 4,688 | $147K | 10/3/2023 | View on chart |
| AHR | ▼ Sell | Tax Withholding | 18,753 | $174K | 10/3/2022 | View on chart |
| AHR | ▲ Buy | Grant | 162,690 | $0 | 10/4/2021 | View on chart |
| AHR | ▲ Buy | Grant | 205,471 | — | 10/1/2021 | View on chart |
| AHR | ▲ Buy | Grant | 20,591 | — | 10/1/2021 | View on chart |
| AHR | ▼ Sell | Other | 20,591 | $190K | 10/1/2021 | View on chart |
| AHR | ▼ Sell | Other | 20,833 | $192K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
AHR Sets Q3 2026 Earnings Date Amid Sector Lag
American Healthcare REIT has announced the dates for its third-quarter 2026 earnings release and conference call. Recent commentary notes that the stock has lagged other finance stocks this year, though some analysts view the current price level as an opportunity driven by senior-care trends. With the stock trading near its 52-week low, the upcoming earnings report will be a key event for investors watching the company's performance.
AHR Sets Q3 2026 Earnings Date Amid Sector Lag. American Healthcare REIT has announced the dates for its third-quarter 2026 earnings release and conference call. Recent commentary notes that the stock has lagged other finance stocks this year, though some analysts view the current price level as an opportunity driven by senior-care trends. With the stock trading near its 52-week low, the upcoming earnings report will be a key event for investors watching the company's performance.